Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05696626 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 34 sites in the US |
| Sponsor | Sermonix Pharmaceuticals Inc. |
| Last Updated on CT.gov | January 26, 2026 (Jan 26, 2026) |
As of March 2, 2026: Clinical trial NCT05696626 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 34 locations across the United States. The study is sponsored by Sermonix Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05696626 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05696626 was last updated Jan 26, 2026 (January 26, 2026). HelloStudys verifies this status automatically.